Background It has been shown that a subgroup of patients with differentiated thyroid cancer
(DTC) and medullary thyroid carcinoma (MTC) would progress to advanced stages of thyroid …

Gastro-entero-pancreatic neuroendocrine neoplasia (GEP-NENs) are rare tumors, but their
frequency is increasing. Neuroendocrine tumors normally express somatostatin (SST) …

Aim The aim of this study was to evaluate the diagnostic accuracy of 18 F-
fluorodeoxyglucose-PET (FDG-PET) and FDG-PET/computed tomography (CT) in the …

The treatment options that are currently available for management of metastatic, progressive
radioactive iodine (RAI)-refractory differentiated thyroid cancers (DTCs), and medullary …

This article provides an update on the use of 2-[18F]-fluoro-2-deoxyglucose PET in the
follow-up of patients treated for differentiated thyroid carcinoma (DTC). Although DTC …

As therapeutic options in advanced medullary and non–iodine avid differentiated
(nonmedullary) thyroid cancers are limited and associated with significant toxicity, targeting …

Background Thyroid cancer is a heterogeneous disease that is classified into differentiated
thyroid carcinoma (DTC), undifferentiated/anaplastic thyroid carcinoma (ATC) and medullary …

Background Positron emission tomography (PET) with fluor-18-deoxy-glucose (FDG) is
widely used for diagnosing recurrent or metastatic disease in patients with differentiated …

Although thyroid cancer is a comparatively rare malignancy, it represents the vast majority of
endocrine cancers and its incidence is increasing. Most differentiated thyroid cancers have …

Purpose: The aim was to evaluate the incremental diagnostic rate of F-18 fluoro-
fluorodeoxygulose positron emission tomography/computed tomography (F-18 FDG …